Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi

Stefano Sacchi; Raffaella Marcheselli; Alessia Bari; Gabriele Buda; A. L. Molinari; Luca Baldini; D. Vallisa; Marina Cesaretti; Pellegrino Musto; Sonia Ronconi; Giorgina Specchia; Franco Silvestris; L. Guardigni; Angela Ferrari; Annalisa Chiapella; Angelo Michele Carella; Armando Santoro; Francesco Di Raimondo; Luigi Marcheselli; Sacchi Samantha Pozzi

doi:10.3324/haematol.2015.139329

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi

Stefano Sacchi, Raffaella Marcheselli, Alessia Bari, Gabriele Buda, A. L. Molinari, Luca Baldini, D. Vallisa, Marina Cesaretti, Pellegrino Musto, Sonia Ronconi, Giorgina Specchia, Franco Silvestris, L. Guardigni, Angela Ferrari, Annalisa Chiapella, Angelo Michele Carella, Armando Santoro, Francesco Di Raimondo, Luigi Marcheselli, Sacchi Samantha Pozzi

Research output: Contribution to journal › Article

Original language	English
Pages (from-to)	e196-e199
Journal	Haematologica
Volume	101
Issue number	5
DOIs	https://doi.org/10.3324/haematol.2015.139329
Publication status	Published - Apr 30 2016

Keywords

Efficacy
Indolent
Lenalidomide
Non-follicular lymphoma
Recurrent
Rituximab
Safety

ASJC Scopus subject areas

Hematology

Access to Document

10.3324/haematol.2015.139329

Cite this

Sacchi, S., Marcheselli, R., Bari, A., Buda, G., Molinari, A. L., Baldini, L., Vallisa, D., Cesaretti, M., Musto, P., Ronconi, S., Specchia, G., Silvestris, F., Guardigni, L., Ferrari, A., Chiapella, A., Carella, A. M., Santoro, A., Di Raimondo, F., Marcheselli, L., & Pozzi, S. S. (2016). Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi. Haematologica, 101(5), e196-e199. https://doi.org/10.3324/haematol.2015.139329

Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma : Final results of a phase II study conducted by the Fondazione Italiana Linfomi. / Sacchi, Stefano; Marcheselli, Raffaella; Bari, Alessia; Buda, Gabriele; Molinari, A. L.; Baldini, Luca; Vallisa, D.; Cesaretti, Marina; Musto, Pellegrino; Ronconi, Sonia; Specchia, Giorgina; Silvestris, Franco; Guardigni, L.; Ferrari, Angela; Chiapella, Annalisa; Carella, Angelo Michele ; Santoro, Armando; Di Raimondo, Francesco; Marcheselli, Luigi; Pozzi, Sacchi Samantha.

In: Haematologica, Vol. 101, No. 5, 30.04.2016, p. e196-e199.

Research output: Contribution to journal › Article

Sacchi, S, Marcheselli, R, Bari, A, Buda, G, Molinari, AL, Baldini, L, Vallisa, D, Cesaretti, M, Musto, P, Ronconi, S, Specchia, G, Silvestris, F, Guardigni, L, Ferrari, A, Chiapella, A, Carella, AM , Santoro, A, Di Raimondo, F, Marcheselli, L & Pozzi, SS 2016, 'Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi', Haematologica, vol. 101, no. 5, pp. e196-e199. https://doi.org/10.3324/haematol.2015.139329

Sacchi, Stefano ; Marcheselli, Raffaella ; Bari, Alessia ; Buda, Gabriele ; Molinari, A. L. ; Baldini, Luca ; Vallisa, D. ; Cesaretti, Marina ; Musto, Pellegrino ; Ronconi, Sonia ; Specchia, Giorgina ; Silvestris, Franco ; Guardigni, L. ; Ferrari, Angela ; Chiapella, Annalisa ; Carella, Angelo Michele ; Santoro, Armando ; Di Raimondo, Francesco ; Marcheselli, Luigi ; Pozzi, Sacchi Samantha. / Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma : Final results of a phase II study conducted by the Fondazione Italiana Linfomi. In: Haematologica. 2016 ; Vol. 101, No. 5. pp. e196-e199.

@article{96c0e56201f04c4bbbf5ec260a3d0c02,

title = "Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma: Final results of a phase II study conducted by the Fondazione Italiana Linfomi",

keywords = "Efficacy, Indolent, Lenalidomide, Non-follicular lymphoma, Recurrent, Rituximab, Safety",

author = "Stefano Sacchi and Raffaella Marcheselli and Alessia Bari and Gabriele Buda and Molinari, {A. L.} and Luca Baldini and D. Vallisa and Marina Cesaretti and Pellegrino Musto and Sonia Ronconi and Giorgina Specchia and Franco Silvestris and L. Guardigni and Angela Ferrari and Annalisa Chiapella and Carella, {Angelo Michele} and Armando Santoro and {Di Raimondo}, Francesco and Luigi Marcheselli and Pozzi, {Sacchi Samantha}",

year = "2016",

month = apr,

day = "30",

doi = "10.3324/haematol.2015.139329",

language = "English",

volume = "101",

pages = "e196--e199",

journal = "Haematologica",

issn = "0390-6078",

publisher = "NLM (Medline)",

number = "5",

}

TY - JOUR

T1 - Safety and efficacy of lenalidomide in combination with rituximab in recurrent indolent non-follicular lymphoma

T2 - Final results of a phase II study conducted by the Fondazione Italiana Linfomi

AU - Sacchi, Stefano

AU - Marcheselli, Raffaella

AU - Bari, Alessia

AU - Buda, Gabriele

AU - Molinari, A. L.

AU - Baldini, Luca

AU - Vallisa, D.

AU - Cesaretti, Marina

AU - Musto, Pellegrino

AU - Ronconi, Sonia

AU - Specchia, Giorgina

AU - Silvestris, Franco

AU - Guardigni, L.

AU - Ferrari, Angela

AU - Chiapella, Annalisa

AU - Carella, Angelo Michele

AU - Santoro, Armando

AU - Di Raimondo, Francesco

AU - Marcheselli, Luigi

AU - Pozzi, Sacchi Samantha

PY - 2016/4/30

Y1 - 2016/4/30

KW - Efficacy

KW - Indolent

KW - Lenalidomide

KW - Non-follicular lymphoma

KW - Recurrent

KW - Rituximab

KW - Safety

UR - http://www.scopus.com/inward/record.url?scp=84964777733&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964777733&partnerID=8YFLogxK

U2 - 10.3324/haematol.2015.139329

DO - 10.3324/haematol.2015.139329

M3 - Article

VL - 101

SP - e196-e199

JO - Haematologica

JF - Haematologica

SN - 0390-6078

IS - 5

ER -